Article
Resistance levels to non-nucleoside reverse transcriptase inhibitors among pregnant women with recent HIV infection in Malawi.
Antiviral therapy - 1 Aug 2022
Bello George, Kagoli Matthew, Chipeta Sikhona, Auld Andrew, Chang Joy C-W, DeVos Joshua R, Kim Evelyn, Mkungudza Jonathan, Payne Danielle, Eliya Michael, Nyirenda Rose, Jahn Andreas, Mzumara Taziona, Mvula Bernard, Dadabhai Sufia, Namakhoma Ireen, Babaye Yusuf, Giron Amalia, Jordan Michael R, Bertagnolio Silvia, O'Malley Gabrielle, Wadonda-Kabondo Nellie
Abstract excerpt
BACKGROUND: Information on HIV drug resistance (HIVDR) prevalence in people newly diagnosed with HIV is limited. We implemented a cross-sectional study to estimate HIVDR prevalence among pregnant women recently infected with HIV in Malawi. METHODS: The HIVDR study was nested within a routine antenatal clinic (ANC) sentinel surveillance survey. Dried blood spot samples were tested for recent infection using a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
